09 maj: Aktier/Europa: Blød landing efter rød dag
10 maj: ESTIMAT Torm Q1 10/5: Underskud før skat 53 mio. dollar
09-05-2012 23:31:00

Telecom Italia 1Q Net Profit EUR606 Million, To Begin Sale Of Media Operations

Relateret indhold

By Giada Zampano

Of DOW JONES NEWSWIRES

ROME -(Dow Jones)- Telecom Italia SpA (TI) said Wednesday its first-quarter net profit rose by 10% as its Latin American operations boosted revenue and its struggling domestic business started to show improving signs.

Telecom Italia also said it decided to start the process for the sale of its media operations in an attempt to focus on its core activities and slash its debt.

Such disposal will help to cut back the company's net debt to its 2012 target of EUR27.5 billion ($35.6 billion). Telecom Italia closely watched net debt dropped to EUR30.3 billion in the first quarter, compared with EUR30.4 billion at the end of December.

Telecom Italia said earlier this week it would examine Wednesday the different strategic options related to its majority stake in broadcasting unit loss-making broadcasting unit Telecom Italia Media SpA (TME.MI).

Telecom Italia Media posted a net loss of EUR15.7 million in the first quarter, compared with a EUR9.2 million loss reported in the same period a year ago.

Over the weekend, press reports said Telecom Italia would decide on the sale of its 77% stake in TI Media, which broadcasts the La7 and Mtv channels, and owns three multiplex.

La7 showed solid margins of growth in 2012, carving a niche in Italy's free-to-air TV market and attracting popular TV hosts and journalists from state broadcaster RAI and Mediaset SpA (MS.MI).

Italy's largest telecommunication operator posted a EUR606 million first-quarter net profit, compared with EUR549 million a year earlier, as revenue grew 4.5% to EUR7.39 billion. The results were slightly above analysts' forecasts, which predicted a EUR557.7 million net profit and EUR7.3 billion in revenue.

Telecom Italia said its consolidated earnings before interest, taxes, depreciation and amortization, or Ebitda, rose 1.2% to EUR2.96 billion on the year.

The Italian operator said its core domestic businesses posted a 3.3% decline in revenue to EUR4.25 billion.

Its Brazilian operations performed strongly, posting a 29.5% jump in profits as net revenue rose by 19% due to growth in voice and data services.

The company added it is confirming all of its targets for 2012.

-By Giada Zampano, Dow Jones Newswires; +39 06 69766920; enza.tedesco@dowjones.com

--Enza Tedesco contributed to this article.

Order free Annual Report for Telecom Italia SpA

Visit http://djnweurope.ar.wilink.com/?ticker=IT0003497168 or call +44 (0)208 391 6028

Order free Annual Report for Telecom Italia SpA

Visit http://djnweurope.ar.wilink.com/?ticker=US87927Y1029 or call +44 (0)208 391 6028

Order free Annual Report for Telecom Italia SpA

Visit http://djnweurope.ar.wilink.com/?ticker=US87927Y2019 or call +44 (0)208 391 6028

(END) Dow Jones Newswires

May 09, 2012 17:31 ET (21:31 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Aktier/tendens: Faldende USA-salg kan sætte fokus på Genmab

23-08-2017 08:23:37
På en onsdag med regnskaber fra flere selskaber uden for C20 Cap kan Genmab komme i fokus, efter at nye tal viser, at salget af kræftmidlet Darzalex faldt på det amerikanske marked i juli i forhold til juni.Generelt vil det dog være "en åbning omkring nul", efter at kursstigninger fra USA ikke har forplantet sig til Asien, fordi der i kulissen igen spøger politisk uro i USA, vurderer Morten Hessne..

Zealand Pharma kan se frem til milepælsbetaling på 4 mio. euro

22-08-2017 16:00:43
Zealand Pharma kan se frem til at modtage 4 mia. euro (30 mio. kr.) som en milepælsbetaling, efter at selskabets tyske partner, Boehringer Ingelheim, har annonceret igangsætningen af to fase-1-studier med et midler udviklet af det danske biotekselskab.De to studier skal vise mulighederne for anvendelsen af medikamenterne til behandling af fedme og/eller diabetes. Det gælder blandt andet lægemiddel..

Matas/Danske: Regnskab med lavere omsætning var forventet

22-08-2017 13:53:03
Matas' regnskab for første kvartal i det forskudte regnskabsår 2017/2018 var som forventet.Det vurderer Poul Ernst Jessen, senioranalytiker i Danske Bank.- Regnskabet er som forventet. Det eneste overraskende er ledelsesændringen, siger Poul Ernst Jessen.Materialistkædens omsætning faldt 3,2 pct. til 820,9 mio. kr., mens driftsresultatet (EBITA) var 119 mio. kr. Danske Bank forventede en omsætning..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Tirsdagens aktier: Pandora tog revanche og stor stigning i C20 Cap
2
Aktier/tendens: Faldende USA-salg kan sætte fokus på Genmab
3
Zealand Pharma kan se frem til milepælsbetaling på 4 mio. euro
4
Bavarian: Johnson & Johnson bliver storaktionær efter samarbejdsaftale
5
Mærsk: Johan Uggla bliver direktør for Maersk Training - citat

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. august 2017 12:00:42
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170821.2 - EUROWEB7 - 2017-08-23 12:00:42 - 2017-08-23 12:00:42 - 1 - Website: OKAY